IsoLoc Prostate Immobilization Treatment Balloon Device Kit, Catalog/UPN: ISO-100

FDA Device Recall #Z-2267-2024 — Class II — May 21, 2024

Recall Summary

Recall Number Z-2267-2024
Classification Class II — Moderate risk
Date Initiated May 21, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Angiodynamics, Inc.
Location Queensbury, NY
Product Type Devices
Quantity 1,500 units (75 kits with 20 units per kit)

Product Description

IsoLoc Prostate Immobilization Treatment Balloon Device Kit, Catalog/UPN: ISO-100

Reason for Recall

A single batch of ISO-100 IsoLoc Gas-Release Endorectal Balloons is mislabeled. The affected ISO-100 balloon catheter has a nominal fill volume of 100cc/ml but the inner pouch identifies the product as an ISO-60 (fill volume of 60cc/ml).

Distribution Pattern

US Nationwide distribution in the states of AZ, FL, IL, MO, MS, NJ, NM, NY, PA, TX, WI.

Lot / Code Information

UPN/Catalog: ISO-100; UDI/DI: 10851546007100 (Box) and 00851546007103 (Pouch); Lot number: 5402.

Other Recalls from Angiodynamics, Inc.

Recall # Classification Product Date
Z-1868-2026 Class II Soft-Vu Angiographic Catheter, Headhunter (1), ... Mar 3, 2026
Z-1862-2026 Class II Soft-Vu Angiographic Catheter, Kumpe, Non-Braid... Mar 3, 2026
Z-1872-2026 Class II AccuVu Angiographic Catheter, Omni Flush, Non-B... Mar 3, 2026
Z-1863-2026 Class II Soft-Vu Angiographic Catheter, Berenstein, Non-... Mar 3, 2026
Z-1873-2026 Class II AccuVu Angiographic Catheter, Straight Flush, N... Mar 3, 2026

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.